Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anesthesiology ; 116(5): 1083-91, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22407285

RESUMEN

BACKGROUND: Myocardial depression is a frequent event during septic shock and may mimic a cardiogenic shock state with decreased cardiac output. Nevertheless, data are scarce regarding the myocardial effects of vasopressors used to treat hypotension. In this study, the authors compared the effects of three commonly used vasopressors acting on different adrenergic receptors on myocardial function in a rodent model of septic shock, as explored with conductance catheter and positron emission tomography. METHODS: Septic shock was induced in rats by peritonitis. Eighteen hours after septic insult, vasopressors were titrated to increase mean arterial pressure by 20% compared with baseline values. RESULTS: We observed that peritonitis was associated with arterial hypotension and systolodiastolic dysfunction. Norepinephrine and epinephrine improved mean arterial pressure, cardiac output, and preload recruitable stroke work, a load-independent measure of systolic function, as well as diastolic function and ventriculoarterial coupling. Heart rate, myocardial oxygen consumption, and arrhythmia incidence were furthermore increased in the epinephrine group. Conversely, phenylephrine, a peripheral α-agonist, exhibited deleterious effects on systolodiastolic function and ventriculoarterial coupling. Conductance catheter and positron emission tomography yielded identical results with regard to myocardial function evolution under vasopressor treatment. CONCLUSIONS: Phenylephrine, a drug without ß-1 effects, was associated with decreased ventricular performance and ventriculoarterial uncoupling, whereas epinephrine and norepinephrine improved global hemodynamics and myocardial function in severely hypokinetic and hypotensive experimental septic shock. Nevertheless, epinephrine was associated with increased myocardial oxygen consumption. Thus, norepinephrine appears to be a more reliable and safer strategy as a first-line therapy in this particular setting.


Asunto(s)
Epinefrina/administración & dosificación , Epinefrina/uso terapéutico , Cardiopatías/tratamiento farmacológico , Norepinefrina/administración & dosificación , Norepinefrina/uso terapéutico , Fenilefrina/administración & dosificación , Fenilefrina/uso terapéutico , Choque Séptico/tratamiento farmacológico , Vasoconstrictores/administración & dosificación , Vasoconstrictores/uso terapéutico , Nucleótidos de Adenina/metabolismo , Animales , Arritmias Cardíacas/etiología , Arritmias Cardíacas/fisiopatología , Presión Sanguínea/fisiología , Gasto Cardíaco/fisiología , Cateterismo , Ciego/lesiones , Cardiopatías/diagnóstico por imagen , Cardiopatías/fisiopatología , Frecuencia Cardíaca/fisiología , Ácido Láctico/metabolismo , Ligadura , Masculino , Contracción Miocárdica/efectos de los fármacos , Miocardio/metabolismo , Miocardio/patología , Consumo de Oxígeno/fisiología , Peritonitis/complicaciones , Fenilefrina/efectos adversos , Tomografía de Emisión de Positrones , Ratas , Ratas Wistar , Choque Séptico/diagnóstico por imagen , Choque Séptico/fisiopatología , Volumen Sistólico/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA